Amsterdam, Noord-Holland, The Netherlands MedSciences Capital is the famous VC, which was founded in 2006. The venture was found in Europe in The Netherlands. The leading representative office of defined VC is situated in the Amsterdam.
Among the most popular portfolio startups of the fund, we may highlight Kiadis Pharma, Mucosis, Pronota. For fund there is a match between the country of its foundation and the country of its the most frequent investments - The Netherlands. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Health Diagnostics, Therapeutics.
Opposing the other organizations, this MedSciences Capital works on 14 percentage points more the average amount of lead investments. The top activity for fund was in 2007. The usual things for fund are deals in the range of 5 - 10 millions dollars. The top amount of exits for fund were in 2015. The real fund results show that this VC is 6 percentage points less often commits exit comparing to other companies. The fund is constantly included in less than 2 investment rounds annually.
The typical case for the fund is to invest in rounds with 3-4 participants. Despite the MedSciences Capital, startups are often financed by Life Sciences Partners, Idinvest Partners, Gimv. The meaningful sponsors for the fund in investment in the same round are NV NOM, Life Sciences Partners, BioGeneration Ventures. In the next rounds fund is usually obtained by Life Sciences Partners, Kreos Capital, BioGeneration Ventures.
Related Funds
| Fund Name | Location |
| Agrifood | Catalonia, Lleida, Spain |
| Cerea Partenaire | France, Ile-de-France, Paris |
| Cyber Wisdom | China, Hong Kong, Kowloon |
| GMH Ventures | Newtown Square, Pennsylvania, United States |
| Haitong Kaiyuan Investment | China, Shanghai |
| Korea Credit Guarantee Fund | Daegu, South Korea, Taegu-jikhalsi |
| Loudwater Investment Partners | England, London, United Kingdom |
| Makeover Solutions | New York, New York, United States |
| Mengxiangzhe Dianying | Beijing, Beijing, China |
| Morgan Stanley Energy Partners | New York, New York, United States |
| OBI SA | - |
| Shangbay Capital | California, Palo Alto, United States |
| Sichuan Haojiaxiang Commercial | China, Gansu, Sichuan |
| Square 1 Bank | Durham, North Carolina, United States |
| Taiwan Tech Arena | - |
| Valve Software | Bellevue, United States, Washington |
| XFactor Ventures | Boston, Massachusetts, United States |
| Yasuda Enterprise Development | Japan, Tokyo |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Net Medical | 01 Jan 2011 | Utrecht | |||
Pronota | $1M | 19 May 2010 | East Flanders | ||
Mucosis | $3M | 10 Sep 2007 | Groningen |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Net Medical | 01 Jan 2011 | Utrecht | |||
Pronota | $1M | 19 May 2010 | East Flanders | ||
Mucosis | $3M | 10 Sep 2007 | Groningen |
